Search Results Search Sort by RelevanceMost Recent In the Literature Jun 2023 Patient-Centered Approaches to Using BMI to Evaluate Gender-Affirming Surgery Eligibility Whitney Riley Linsenmeyer, PhD, RD, LD and Sarah Garwood, MD Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based. AMA J Ethics. 2023;25(6):E398-406. doi: 10.1001/amajethics.2023.398. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. In the Literature Jul 2014 What We Talk about When We Talk about Performance Enhancement Andrew Courtwright, MD, PhD Distinctions between treatment and enhancement, and between supposedly authentic and inauthentic tools, often inform judgments about what is morally acceptable in sport. Virtual Mentor. 2014;16(7):543-546. doi: 10.1001/virtualmentor.2014.16.7.jdsc1-1407. In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28. In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.
In the Literature Jun 2023 Patient-Centered Approaches to Using BMI to Evaluate Gender-Affirming Surgery Eligibility Whitney Riley Linsenmeyer, PhD, RD, LD and Sarah Garwood, MD Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based. AMA J Ethics. 2023;25(6):E398-406. doi: 10.1001/amajethics.2023.398.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
In the Literature Jul 2014 What We Talk about When We Talk about Performance Enhancement Andrew Courtwright, MD, PhD Distinctions between treatment and enhancement, and between supposedly authentic and inauthentic tools, often inform judgments about what is morally acceptable in sport. Virtual Mentor. 2014;16(7):543-546. doi: 10.1001/virtualmentor.2014.16.7.jdsc1-1407.
In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28.
In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.